Aurobindo Receives Yet Another Approval From MCC South Africa

Aurobindo Pharma Ltd has announced that the Company has received another marketing authorization approval from Medicines Control Council (MCC) of South Africa. The Council has approved Stavudine tablets in 30mg and 40mg strengths.

South African market is highly regulated and very important in its Geographical sphere. The Company by bagging this approval makes further inroads into this market as with Stavudine, the Company has five of its ARV's products approved.

Stavudine is an antiviral agent of the nucleoside analog class (NRTI). The international brand name is Zerit and is marketed by Bristol Myers Squibb. Stavudine is used in combination with other NRTIs and NNRTIs class of drugs in HIV patients.

Stavudine enjoys a market of over 30 mio USD in South Africa.

Source : Equity Bulls

Keywords